Use of contrast enhanced MRI in the assessment of therapeutic response to a disease-modifying antirheumatic drug. Case study of a patient with rheumatoid arthritis--6- and 24-month follow up

Br J Rheumatol. 1995 Oct;34(10):956-9. doi: 10.1093/rheumatology/34.10.956.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Arthritis, Rheumatoid / diagnostic imaging
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / pathology
  • Drug Monitoring
  • Female
  • Follow-Up Studies
  • Humans
  • Isoxazoles / therapeutic use*
  • Leflunomide
  • Magnetic Resonance Imaging / methods
  • Metacarpophalangeal Joint / diagnostic imaging
  • Metacarpophalangeal Joint / pathology
  • Middle Aged
  • Prospective Studies
  • Radiography
  • Single-Blind Method
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Isoxazoles
  • Leflunomide